The emerging roles of artificial intelligence in cancer drug development and precision therapy.

Researchers

Journal

Modalities

Models

Abstract

Artificial intelligence (AI) has strong logical reasoning ability and independent learning ability, which can simulate the thinking process of the human brain. AI technologies such as machine learning can profoundly optimize the existing mode of anticancer drug research. But at present AI also has its relative limitation. In this paper, the development of artificial intelligence technology such as deep learning and machine learning in anticancer drug research is reviewed. At the same time, we look forward to the future of AI.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.